{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:24:26Z","timestamp":1790713466304,"version":"4.1.0"},"reference-count":226,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T00:00:00Z","timestamp":1587686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"DOI":"10.3389\/fbioe.2020.00323","type":"journal-article","created":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T04:47:50Z","timestamp":1587703670000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":25,"title":["Combining Nanomaterials and Developmental Pathways to Design New Treatments for Cardiac Regeneration: The Pulsing Heart of Advanced Therapies"],"prefix":"10.3389","volume":"8","author":[{"given":"Marco","family":"Cassani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraia","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Vrbsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ece","family":"Ergir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Cavalieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Forte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,4,24]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","DOI":"10.1186\/1556-276X-8-102","article-title":"Liposome: classification, preparation, and applications.","volume":"8","author":"Akbarzadeh","year":"2013","journal-title":"Nanoscale Res. Lett."},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2014.205","article-title":"Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity.","volume":"17","author":"Alfares","year":"2015","journal-title":"Genet. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.jconrel.2016.12.042","article-title":"Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction.","volume":"247","author":"Allijn","year":"2017","journal-title":"J. Controll. Release"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/nano6070133","article-title":"Nanomaterials for cardiac myocyte tissue engineering.","volume":"6","author":"Amezcua","year":"2016","journal-title":"Nanomaterials (Basel)"},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.30278","article-title":"SAV1 promotes Hippo kinase activation through antagonizing the PP2A phosphatase STRIPAK.","volume":"6","author":"Bae","year":"2017","journal-title":"Elife"},{"key":"B6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1161\/circresaha.118.311217","article-title":"Clinical studies of cell therapy in cardiovascular medicine recent developments and future directions.","volume":"123","author":"Banerjee","year":"2018","journal-title":"Circ. Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1002\/wnan.1364","article-title":"Polymeric nanoparticles: the future of nanomedicine.","volume":"8","author":"Banik","year":"2016","journal-title":"Wiley Interdiscipl. Rev. Nanomed. Nanobiotechnol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions.","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"key":"B9","first-page":"648","article-title":"Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial.","volume":"38","author":"Bartunek","year":"2017","journal-title":"Eur. Heart J."},{"key":"B10","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nrcardio.2014.9","article-title":"Cell therapy for cardiac repair\u2014lessons from clinical trials.","volume":"11","author":"Behfar","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"5885","DOI":"10.1021\/acs.nanolett.8b02578","article-title":"Nanoparticle delivery of miRNA-21 mimic to cardiac macrophages improves myocardial remodeling after myocardial infarction.","volume":"18","author":"Bejerano","year":"2018","journal-title":"Nano Lett."},{"key":"B12","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1126\/science.1164680","article-title":"Evidence for cardiomyocyte renewal in humans.","volume":"324","author":"Bergmann","year":"2009","journal-title":"Science"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1007\/s11095-016-1958-5","article-title":"Nanoparticle-based medicines: a review of FDA-approved materials and clinical trials to date.","volume":"33","author":"Bobo","year":"2016","journal-title":"Pharm. Res."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1126\/science.1174381","article-title":"MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice.","volume":"324","author":"Bonauer","year":"2009","journal-title":"Science"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/nature11919","article-title":"MicroRNA-34a regulates cardiac ageing and function.","volume":"495","author":"Boon","year":"2013","journal-title":"Nature"},{"key":"B16","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1161\/atvbaha.112.300139","article-title":"Intercellular transport of microRNAs.","volume":"33","author":"Boon","year":"2013","journal-title":"Arterioscler. Thrombos. Vasc. Biol."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2019.00049","article-title":"Role of hippo pathway-YAP\/TAZ signaling in angiogenesis.","volume":"7","author":"Boopathy","year":"2019","journal-title":"Front. Cell Dev. Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1161\/circresaha.119.314951","article-title":"Phase 3 DREAM-HF trial of mesenchymal precursor cells in chronic heart failure.","volume":"125","author":"Borow","year":"2019","journal-title":"Circ. Res."},{"key":"B19","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1111\/j.1440-1681.2011.05649.x","article-title":"Early origins of heart disease: low birth weight and determinants of cardiomyocyte endowment.","volume":"39","author":"Botting","year":"2012","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.yrtph.2015.06.001","article-title":"Comparative assessment of nanomaterial definitions and safety evaluation considerations.","volume":"73","author":"Boverhof","year":"2015","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"B21","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1161\/CIRCRESAHA.117.311812","article-title":"Cardiomyopathies.","volume":"121","author":"Braunwald","year":"2017","journal-title":"Circ. Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1136\/heartjnl-2015-308037","article-title":"Ischaemic cardiomyopathy: pathophysiology, assessment and the role of revascularisation.","volume":"102","author":"Briceno","year":"2016","journal-title":"Heart"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics9020012","article-title":"Liposomal formulations in clinical use: an updated review.","volume":"9","author":"Bulbake","year":"2017","journal-title":"Pharmaceutics"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1016\/j.jacc.2016.08.079","article-title":"Clinical and mechanistic insights into the genetics of cardiomyopathy.","volume":"68","author":"Burke","year":"2016","journal-title":"J. Am. Coll Cardiol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1161\/circresaha.116.309717","article-title":"Intravenous allogeneic mesenchymal stem cells for nonischemic cardiomyopathy safety and efficacy results of a phase II-A randomized trial.","volume":"120","author":"Butler","year":"2017","journal-title":"Circ. Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1161\/circresaha.113.300282","article-title":"Genetic cardiomyopathies causing heart failure.","volume":"113","author":"Cahill","year":"2013","journal-title":"ESC Heart Fail"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.201801313","article-title":"Oil core\u2013PEG shell nanocarriers for in vivo MRI imaging.","volume":"8","author":"Calcagno","year":"2019","journal-title":"Adv. Healthc. Mater."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1172\/jci36154","article-title":"MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice.","volume":"119","author":"Callis","year":"2009","journal-title":"J. Clin. Investig."},{"key":"B29","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes.","volume":"372","author":"Cannon","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1126\/science.aaf1502","article-title":"Conversion of human fibroblasts into functional cardiomyocytes by small molecules.","volume":"352","author":"Cao","year":"2016","journal-title":"Science"},{"key":"B31","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nm1582","article-title":"MicroRNA-133 controls cardiac hypertrophy.","volume":"13","author":"Car\u00e8","year":"2007","journal-title":"Nat. Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1161\/circresaha.117.311974","article-title":"Considerations for cardiac CRISPR.","volume":"121","author":"Carroll","year":"2017","journal-title":"Circ. Res."},{"key":"B33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/HCO.0000000000000386","article-title":"Cardiac gene therapy with adeno-associated virus-based vectors.","volume":"32","author":"Chamberlain","year":"2017","journal-title":"Curr. Opin. Cardiol."},{"key":"B34","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.mpmed.2018.07.014","article-title":"Cardiomyopathies.","volume":"46","author":"Chan","year":"2018","journal-title":"Medicine"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1007\/s13204-018-0856-z","article-title":"The use of nanotechnology in cardiovascular disease.","volume":"8","author":"Chandarana","year":"2018","journal-title":"Nanomedicine"},{"key":"B36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/cce2.68","article-title":"Recent advances in cardiac gene therapy strategies targeting advanced heart failure.","volume":"3","author":"Chen","year":"2017","journal-title":"Continu. Cardiol. Educ."},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00060","article-title":"WW domain-containing proteins YAP and TAZ in the hippo pathway as key regulators in stemness maintenance, tissue homeostasis, and tumorigenesis.","volume":"9","author":"Chen","year":"2019","journal-title":"Front. Oncol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.1002\/adhm.201600724","article-title":"Biomimicking platelet\u2013monocyte interactions as a novel targeting strategy for heart healing.","volume":"5","author":"Cheng","year":"2016","journal-title":"Adv. Healthc. Mater."},{"key":"B39","doi-asserted-by":"crossref","DOI":"10.1186\/s40824-019-0166-x","article-title":"Therapeutic efficacy of nanoparticles and routes of administration.","volume":"23","author":"Chenthamara","year":"2019","journal-title":"Biomater. Res."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050536","article-title":"MicroRNA 218 mediates the effects of Tbx5a over-expression on zebrafish heart development.","volume":"7","author":"Chiavacci","year":"2012","journal-title":"PLoS ONE"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/j.stemcr.2017.09.003","article-title":"Human induced pluripotent stem cell-derived cardiomyocyte encapsulating bioactive hydrogels improve rat heart function post myocardial infarction.","volume":"9","author":"Chow","year":"2017","journal-title":"Stem Cell Rep."},{"key":"B42","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1080\/15384101.2018.1464852","article-title":"Molecular basis of functional myogenic specification of Bona Fide multipotent adult cardiac stem cells.","volume":"17","author":"Cianflone","year":"2018","journal-title":"Cell Cycle"},{"key":"B43","doi-asserted-by":"publisher","first-page":"17831","DOI":"10.1073\/pnas.1910962116","article-title":"Disrupted mechanobiology links the molecular and cellular phenotypes in familial dilated cardiomyopathy.","volume":"116","author":"Clippinger","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1002\/ar.22973","article-title":"Structural implications of \u03b2-cardiac myosin heavy chain mutations in human disease.","volume":"297","author":"Colegrave","year":"2014","journal-title":"Anatom. Rec."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2014.00048","article-title":"Revisiting 30 years of biofunctionalization and surface chemistry of inorganic nanoparticles for nanomedicine.","volume":"2","author":"Conde","year":"2014","journal-title":"Front. Chem."},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201604634","article-title":"Degradability and clearance of silicon, organosilica, silsesquioxane, silica mixed oxide, and mesoporous silica nanoparticles.","volume":"29","author":"Croissant","year":"2017","journal-title":"Adv. Mater."},{"key":"B47","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jconrel.2016.11.015","article-title":"To exploit the tumor microenvironment: since the EPR effect fails in the clinic, what is the future of nanomedicine?","volume":"244","author":"Danhier","year":"2016","journal-title":"J. Controll. Release"},{"key":"B48","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/nrd2614","article-title":"Nanoparticle therapeutics: an emerging treatment modality for cancer.","volume":"7","author":"Davis","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"B49","article-title":"Stress-induced cardiomyopathy: as a diagnosis that is time sensitive and anticipative in certain individuals.","volume":"2018","author":"Dhulipala","year":"2018","journal-title":"Case Rep. Cardiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s12265-010-9253-z","article-title":"Cell therapy for cardiovascular disease: a comparison of methods of delivery.","volume":"4","author":"Dib","year":"2011","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"7291","DOI":"10.2147\/ijn.s146315","article-title":"Effective use of nanocarriers as drug delivery systems for the treatment of selected tumors.","volume":"12","author":"Din","year":"2017","journal-title":"Int. J. Nanomed."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2866","article-title":"Nfat and miR-25 cooperate to reactivate the transcription factor Hand2 in heart failure.","volume":"15","author":"Dirkx","year":"2013","journal-title":"Nat. Cell Biol."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.msec.2019.109751","article-title":"A bioresorbable biomaterial carrier and passive stabilization device to improve heart function post-myocardial infarction.","volume":"103","author":"Dolan","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1126\/science.1258096","article-title":"The new frontier of genome engineering with CRISPR-Cas9.","volume":"346","author":"Doudna","year":"2014","journal-title":"Science"},{"key":"B55","doi-asserted-by":"publisher","first-page":"4411","DOI":"10.1021\/nl2025882","article-title":"Nanoparticles targeting the infarcted heart.","volume":"11","author":"Dvir","year":"2011","journal-title":"Nano Lett."},{"key":"B56","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ijpharm.2017.06.052","article-title":"Polymeric nanoparticles: promising platform for drug delivery.","volume":"528","author":"El-Say","year":"2017","journal-title":"Int. J. Pharm."},{"key":"B57","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1435746","article-title":"Direct cardiac reprogramming: progress and promise.","volume":"2018","author":"Engel","year":"2018","journal-title":"Stem Cells Int."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2017.03.006","article-title":"Tropomyosin 1: multiple roles in the developing heart and in the formation of congenital heart defects.","volume":"106","author":"England","year":"2017","journal-title":"J. Mol. Cell Cardiol."},{"key":"B59","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1161\/01.cir.104.1.115","article-title":"Angiogenesis therapy: amidst the hype, the neglected potential for serious side effects.","volume":"104","author":"Epstein","year":"2001","journal-title":"Circulation"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.01417","article-title":"Small Force, big impact: next generation organ-on-a-chip systems incorporating biomechanical cues.","volume":"9","author":"Ergir","year":"2018","journal-title":"Front. Physiol."},{"key":"B61","first-page":"680","article-title":"Cardiomyocyte regeneration.","volume":"136","author":"Eschenhagen","year":"2017","journal-title":"Cells"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/nature11739","article-title":"Functional screening identifies miRNAs inducing cardiac regeneration.","volume":"492","author":"Eulalio","year":"2012","journal-title":"Nature"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00133","article-title":"Hide and seek: nanomaterial interactions with the immune system.","volume":"10","author":"Fadeel","year":"2019","journal-title":"Front. Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1016\/j.jacc.2005.09.074","article-title":"Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease.","volume":"47","author":"Feringa","year":"2006","journal-title":"J. Am. College Cardiol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"22701","DOI":"10.1039\/c8nr05933k","article-title":"Polymer nanoparticles for the intravenous delivery of anticancer drugs: the checkpoints on the road from the synthesis to clinical translation.","volume":"10","author":"Ferrari","year":"2018","journal-title":"Nanoscale"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201705134","article-title":"Dual-drug delivery using dextran-functionalized nanoparticles targeting cardiac fibroblasts for cellular reprogramming.","volume":"28","author":"Ferreira","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"B67","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.devcel.2008.07.008","article-title":"miR-126 regulates angiogenic signaling and vascular integrity.","volume":"15","author":"Fish","year":"2008","journal-title":"Dev. Cell"},{"key":"B68","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/j.celrep.2015.02.027","article-title":"YAP inhibition restores hepatocyte differentiation in advanced HCC, leading to tumor regression.","volume":"10","author":"Fitamant","year":"2015","journal-title":"Cell Rep."},{"key":"B69","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1242\/dev.132910","article-title":"Building and re-building the heart by cardiomyocyte proliferation.","volume":"143","author":"Foglia","year":"2016","journal-title":"Development"},{"key":"B70","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-39107-3","article-title":"Polymeric engineering of nanoparticles for highly efficient multifunctional drug delivery systems.","volume":"9","author":"Fortuni","year":"2019","journal-title":"Sci. Rep."},{"key":"B71","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/cr.2015.99","article-title":"Direct reprogramming of mouse fibroblasts into cardiomyocytes with chemical cocktails.","volume":"25","author":"Fu","year":"2015","journal-title":"Cell Res."},{"key":"B72","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1038\/sj.onc.1207389","article-title":"The many faces of \u03b2-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer.","volume":"23","author":"Fuchs","year":"2004","journal-title":"Oncogene"},{"key":"B73","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/s41586-019-1191-6","article-title":"MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs.","volume":"569","author":"Gabisonia","year":"2019","journal-title":"Nature"},{"key":"B74","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09530-1","article-title":"Therapeutic role of miR-19a\/19b in cardiac regeneration and protection from myocardial infarction.","volume":"10","author":"Gao","year":"2019","journal-title":"Nat. Commun."},{"key":"B75","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1093\/eurheartj\/ehp342","article-title":"Repeated implantation of skeletal myoblast in a swine model of chronic myocardial infarction.","volume":"31","author":"Gavira","year":"2010","journal-title":"Eur. Heart J."},{"key":"B76","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.yjmcc.2015.09.017","article-title":"Harnsessing the microRNA pathway for cardiac regeneration.","volume":"89","author":"Giacca","year":"2015","journal-title":"J. Mol. Cell Cardiol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.mattod.2015.07.004","article-title":"Inorganic nanoparticles for biomedicine: where materials scientists meet medical research.","volume":"19","author":"Giner-Casares","year":"2016","journal-title":"Mater. Today"},{"key":"B78","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.addr.2018.07.007","article-title":"Tumor targeting via EPR: strategies to enhance patient responses.","volume":"130","author":"Golombek","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0174118","article-title":"The clinical features, outcomes and genetic characteristics of hypertrophic cardiomyopathy patients with severe right ventricular hypertrophy","volume":"12","author":"Guo","year":"2017","journal-title":"PLoS One."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1073\/pnas.1015623108","article-title":"Modulation of cardiac macrophages by phosphatidylserine-presenting liposomes improves infarct repair.","volume":"108","author":"Harel-Adar","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B81","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41569-018-0036-6","article-title":"Therapeutic approaches for cardiac regeneration and repair.","volume":"15","author":"Hashimoto","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.cr.2018.11.002","article-title":"Molecular switch model for cardiomyocyte proliferation.","volume":"8","author":"Hashmi","year":"2019","journal-title":"Cell Regen. (Lond.)"},{"key":"B83","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.addr.2014.08.006","article-title":"Drug and cell delivery for cardiac regeneration.","volume":"84","author":"Hastings","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"B84","doi-asserted-by":"publisher","first-page":"4683","DOI":"10.1242\/dev.102798","article-title":"Hippo signaling impedes adult heart regeneration.","volume":"140","author":"Heallen","year":"2013","journal-title":"Development"},{"key":"B85","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1126\/science.1199010","article-title":"Hippo pathway inhibits wnt signaling to restrain cardiomyocyte proliferation and heart size.","volume":"332","author":"Heallen","year":"2011","journal-title":"Science"},{"key":"B86","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/s0140-6736(02)09327-3","article-title":"MRC\/BHF heart protection study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial.","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"B87","doi-asserted-by":"publisher","first-page":"14436","DOI":"10.1073\/pnas.1515202112","article-title":"Nanotechnologies for biomedical science and translational medicine.","volume":"112","author":"Heath","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B88","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1161\/01.CIR.0000061911.47710.8A","article-title":"The VIVA trial.","volume":"107","author":"Henry","year":"2003","journal-title":"Circulation"},{"key":"B89","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1067\/mhj.2001.118471","article-title":"Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary artery disease.","volume":"142","author":"Henry","year":"2001","journal-title":"Am. Heart J."},{"key":"B90","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1038\/nrcardio.2013.105","article-title":"Dilated cardiomyopathy: the complexity of a diverse genetic architecture.","volume":"10","author":"Hershberger","year":"2013","journal-title":"Nat. Rev. Cardiol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1161\/circgenetics.108.846733","article-title":"Clinical and functional characterization of TNNT2 mutations identified in patients with dilated cardiomyopathy.","volume":"2","author":"Hershberger","year":"2009","journal-title":"Circulation"},{"key":"B92","article-title":"Loss of microRNA-128 promotes cardiomyocyte proliferation and heart regeneration.","volume":"9","author":"Huang","year":"2018","journal-title":"Nat. Commun."},{"key":"B93","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cell.2010.07.002","article-title":"Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors.","volume":"142","author":"Ieda","year":"2010","journal-title":"Cell"},{"key":"B94","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1161\/circresaha.118.314048","article-title":"Hippo deficiency leads to cardiac dysfunction accompanied by cardiomyocyte dedifferentiation during pressure overload.","volume":"124","author":"Ikeda","year":"2019","journal-title":"Circ. Res."},{"key":"B95","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jjcc.2018.10.002","article-title":"Progress and challenge of cardiac regeneration to treat heart failure.","volume":"73","author":"Isomi","year":"2019","journal-title":"J. Cardiol."},{"key":"B96","first-page":"4391","article-title":"Nanotechnology-based approaches in anticancer research.","volume":"7","author":"Jabir","year":"2012","journal-title":"Int. J. Nanomed."},{"key":"B97","doi-asserted-by":"crossref","first-page":"481","DOI":"10.4103\/IJPM.IJPM_213_16","article-title":"Histological and morphometric analysis of dilated cardiomyopathy with special reference to collagen IV expression.","volume":"60","author":"Jain","year":"2017","journal-title":"Ind. J. Pathol. Microbiol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1161\/circresaha.112.269035","article-title":"MicroRNA-mediated in vitro and in vivo direct reprogramming of cardiac fibroblasts to cardiomyocytes.","volume":"110","author":"Jayawardena","year":"2012","journal-title":"Circ. Res."},{"key":"B99","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA\u2013guided DNA endonuclease in adaptive bacterial immunity.","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"key":"B100","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1161\/01.cir.0000027563.44593.cc","article-title":"Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease.","volume":"106","author":"Juul","year":"2002","journal-title":"Circulation"},{"key":"B101","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ijcard.2016.02.145","article-title":"MicroRNA deep sequencing reveals chamber-specific miR-208 family expression patterns in the human heart.","volume":"211","author":"Kakimoto","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.apsb.2015.07.003","article-title":"Insoluble drug delivery strategies: review of recent advances and business prospects.","volume":"5","author":"Kalepu","year":"2015","journal-title":"Acta Pharm. Sin. B"},{"key":"B103","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1016\/j.msec.2019.01.066","article-title":"Employment of enhanced permeability and retention effect (EPR): nanoparticle-based precision tools for targeting of therapeutic and diagnostic agent in cancer.","volume":"98","author":"Kalyane","year":"2019","journal-title":"Mater. Sci. Eng. C"},{"key":"B104","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1161\/circulationaha.113.002870","article-title":"Nanoparticle-mediated delivery of pitavastatin inhibits atherosclerotic plaque destabilization\/rupture in mice by regulating the recruitment of inflammatory monocytes.","volume":"129","author":"Katsuki","year":"2014","journal-title":"Circulation"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1016\/j.nano.2018.06.003","article-title":"CT imaging of myocardial scar burden with CNA35-conjugated gold nanoparticles.","volume":"14","author":"Kee","year":"2018","journal-title":"Nanomedicine"},{"key":"B106","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00795-y","article-title":"Stable MOB1 interaction with Hippo\/MST is not essential for development and tissue growth control.","volume":"8","author":"Kulaberoglu","year":"2017","journal-title":"Nat. Commun."},{"key":"B107","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1261\/rna.804508","article-title":"Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors.","volume":"14","author":"Lee","year":"2008","journal-title":"RNA"},{"key":"B108","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/s41551-017-0137-2","article-title":"Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homology-directed DNA repair.","volume":"1","author":"Lee","year":"2017","journal-title":"Nat. Biomed. Eng."},{"key":"B109","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.jconrel.2019.10.007","article-title":"MicroRNA delivery through nanoparticles.","volume":"313","author":"Lee","year":"2019","journal-title":"J. Controll. Release"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1002\/adma.201902575","article-title":"Fast and efficient CRISPR\/Cas9 genome editing in vivo enabled by bioreducible lipid and messenger RNA nanoparticles.","volume":"31","author":"Liu","year":"2019","journal-title":"Adv. Mater."},{"key":"B111","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1101\/gad.1738708","article-title":"microRNA-133a regulates cardiomyocyte proliferation and suppresses smooth muscle gene expression in the heart.","volume":"22","author":"Liu","year":"2008","journal-title":"Genes Dev."},{"key":"B112","doi-asserted-by":"publisher","first-page":"20844","DOI":"10.1073\/pnas.0710558105","article-title":"An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133.","volume":"104","author":"Liu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B113","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1136\/heartjnl-2014-306387","article-title":"Novel genotype-phenotype associations demonstrated by high-throughput sequencing in patients with hypertrophic cardiomyopathy.","volume":"101","author":"Lopes","year":"2015","journal-title":"Heart"},{"key":"B114","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1161\/circresaha.114.302213","article-title":"Inhibition of MicroRNA-92a prevents endothelial dysfunction and atherosclerosis in mice.","volume":"114","author":"Loyer","year":"2014","journal-title":"Circ. Res."},{"key":"B115","first-page":"865","article-title":"Biophysics.","volume":"72","author":"Lu","year":"2015","journal-title":"Myocardial Infarct."},{"key":"B116","doi-asserted-by":"crossref","DOI":"10.1038\/srep25613","article-title":"Distribution of systemically administered nanoparticles reveals a size-dependent effect immediately following cardiac ischaemia-reperfusion injury.","volume":"6","author":"Lundy","year":"2016","journal-title":"Sci. Rep."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1093\/eurheartj\/ehw113","article-title":"Position paper of the european society of cardiology working group cellular biology of the heart: cell-based therapies for myocardial repair and regeneration in ischemic heart disease and heart failure.","volume":"37","author":"Madonna","year":"2016","journal-title":"Eur. Heart J."},{"key":"B118","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/circresaha.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy.","volume":"121","author":"Marian","year":"2017","journal-title":"Circ. Res."},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00371","article-title":"Role of c-kit in myocardial regeneration and aging.","volume":"10","author":"Marino","year":"2019","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00824","article-title":"Cellular mechanotransduction: from tension to function.","volume":"9","author":"Martino","year":"2018","journal-title":"Front. Physiol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1038\/s41436-018-0046-0","article-title":"Defining the diagnostic effectiveness of genes for inclusion in panels: the experience of two decades of genetic testing for hypertrophic cardiomyopathy at a single center.","volume":"21","author":"Mazzarotto","year":"2019","journal-title":"Genet. Med."},{"key":"B122","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/s41569-018-0013-0","article-title":"Cell therapy trials for heart regeneration \u2014 lessons learned and future directions.","volume":"15","author":"Menasch\u00e9","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1101\/gad.274027.115","article-title":"Mechanisms of hippo pathway regulation.","volume":"30","author":"Meng","year":"2016","journal-title":"Genes Dev."},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan6205","article-title":"Inhalation of peptide-loaded nanoparticles improves heart failure.","volume":"10","author":"Miragoli","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"B125","doi-asserted-by":"publisher","first-page":"243","DOI":"10.12865\/CHSJ.44.03.07","article-title":"Histopathological aspects of the myocardium in dilated cardiomyopathy.","volume":"44","author":"Mitrut","year":"2018","journal-title":"Curr. Health Sci. J."},{"key":"B126","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003918","article-title":"Phase I clinical trial of autologous stem cell-sheet transplantation therapy for treating cardiomyopathy.","volume":"6","author":"Miyagawa","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"B127","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.mod.2010.09.002","article-title":"Heartbeat regulates cardiogenesis by suppressing retinoic acid signaling via expression of miR-143.","volume":"128","author":"Miyasaka","year":"2011","journal-title":"Mech. Dev."},{"key":"B128","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cell.2018.02.014","article-title":"Regulation of cell cycle to stimulate adult cardiomyocyte proliferation and cardiac regeneration.","volume":"173","author":"Mohamed","year":"2018","journal-title":"Cell"},{"key":"B129","doi-asserted-by":"publisher","first-page":"17830","DOI":"10.1073\/pnas.0804673105","article-title":"microRNA-138 modulates cardiac patterning during embryonic development.","volume":"105","author":"Morton","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B130","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1161\/circresaha.117.310982","article-title":"Restrictive cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy.","volume":"121","author":"Muchtar","year":"2017","journal-title":"Circ. Res."},{"key":"B131","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1159\/000492704","article-title":"Stem cell therapy in heart diseases \u2013 Cell types, mechanisms and improvement strategies.","volume":"48","author":"M\u00fcller","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"B132","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1073\/pnas.1301019110","article-title":"Reprogramming of human fibroblasts toward a cardiac fate.","volume":"110","author":"Nam","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B133","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15321","article-title":"YAP regulates cell mechanics by controlling focal adhesion assembly.","volume":"8","author":"Nardone","year":"2017","journal-title":"Nat. Commun."},{"key":"B134","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nrcardio.2010.16","article-title":"Mechanisms of stress (Takotsubo) cardiomyopathy.","volume":"7","author":"Nef","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"5547","DOI":"10.1002\/adma.201502003","article-title":"Enzyme-responsive nanoparticles for targeted accumulation and prolonged retention in heart tissue after myocardial infarction.","volume":"27","author":"Nguyen","year":"2015","journal-title":"Adv. Mater."},{"key":"B136","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1161\/01.res.0000265846.23485.7a","article-title":"Inhibition of endogenous Mst1 prevents apoptosis and cardiac dysfunction without affecting cardiac hypertrophy after myocardial infarction.","volume":"100","author":"Odashima","year":"2007","journal-title":"Circ. Res."},{"key":"B137","doi-asserted-by":"crossref","first-page":"H278","DOI":"10.1152\/ajpheart.00471.2017","article-title":"VEGF nanoparticles repair the heart after myocardial infarction.","volume":"314","author":"Oduk","year":"2018","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"B138","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.ijpharm.2008.09.039","article-title":"Polymeric nanoparticles for siRNA delivery and gene silencing.","volume":"367","author":"Patil","year":"2009","journal-title":"Int. J. Pharm."},{"key":"B139","doi-asserted-by":"crossref","DOI":"10.1186\/s12951-018-0392-8","article-title":"Nano based drug delivery systems: recent developments and future prospects.","volume":"16","author":"Patra","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"B140","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jconrel.2012.06.035","article-title":"Distribution of lipid-based nanoparticles to infarcted myocardium with potential application for MRI-monitored drug delivery.","volume":"162","author":"Paulis","year":"2012","journal-title":"J. Controll. Release"},{"key":"B141","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1021\/acsnano.6b06040","article-title":"Diverse applications of nanomedicine.","volume":"11","author":"Pelaz","year":"2017","journal-title":"ACS Nano"},{"key":"B142","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1089\/hum.2016.166","article-title":"Randomized clinical trials of gene transfer for heart failure with reduced ejection fraction.","volume":"28","author":"Penny","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"B143","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1016\/j.molcel.2016.10.034","article-title":"Characterization of hippo pathway components by gene inactivation.","volume":"64","author":"Plouffe","year":"2016","journal-title":"Mol. Cell"},{"key":"B144","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/nrcardio.2015.108","article-title":"Viral myocarditis\u2014diagnosis, treatment options, and current controversies.","volume":"12","author":"Pollack","year":"2015","journal-title":"Nat. Rev. Cardiol."},{"key":"B145","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.2217\/nnm-2017-0309","article-title":"Silica nanoparticles actively engage with mesenchymal stem cells in improving acute functional cardiac integration.","volume":"13","author":"Popara","year":"2018","journal-title":"Nanomedicine"},{"key":"B146","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1161\/circresaha.111.248880","article-title":"miR-15 Family regulates postnatal mitotic arrest of cardiomyocytes.","volume":"109","author":"Porrello","year":"","journal-title":"Circ. Res."},{"key":"B147","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1126\/science.1200708","article-title":"Transient regenerative potential of the neonatal mouse heart.","volume":"331","author":"Porrello","year":"","journal-title":"Science"},{"key":"B148","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1016\/j.jcin.2010.05.016","article-title":"Reparative effects of allogeneic mesenchymal precursor cells delivered transendocardially in experimental nonischemic cardiomyopathy.","volume":"3","author":"Psaltis","year":"2010","journal-title":"JACC"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1186\/2045-3701-3-31","article-title":"Mst1 and Mst2 kinases: regulations and diseases.","volume":"3","author":"Qin","year":"2013","journal-title":"Cell Biosci."},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1002\/adfm.201704939","article-title":"Photoacoustic imaging of embryonic stem cell-derived cardiomyocytes in living hearts with ultrasensitive semiconducting polymer nanoparticles.","volume":"28","author":"Qin","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"B151","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ncrna.2017.03.001","article-title":"Cardiac regenerative medicine: at the crossroad of microRNA function and biotechnology.","volume":"2","author":"Raso","year":"2017","journal-title":"Non-coding RNA Res."},{"key":"B152","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.ahj.2018.03.016","article-title":"The CardiAMP heart failure trial: a randomized controlled pivotal trial of high-dose autologous bone marrow mononuclear cells using the CardiAMP cell therapy system in patients with post\u2013myocardial infarction heart failure: trial rationale and study design.","volume":"201","author":"Raval","year":"2018","journal-title":"Am. Heart J."},{"key":"B153","first-page":"271","article-title":"Cardiac regeneration using growth factors: advances and challenges.","volume":"107","author":"Rebou\u00e7as","year":"2016","journal-title":"Arq. Bras. Cardiol."},{"key":"B154","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.biopha.2018.10.065","article-title":"Stem cells as therapy for heart disease: iPSCs, ESCs, CSCs, and skeletal myoblasts.","volume":"109","author":"Rikhtegar","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"B155","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.pharmthera.2015.10.006","article-title":"Growth and differentiation factor 11 (GDF11): functions in the regulation of erythropoiesis and cardiac regeneration.","volume":"156","author":"Rochette","year":"2015","journal-title":"Pharmacol. Therapeut."},{"key":"B156","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.copbio.2018.08.009","article-title":"Tomorrow today: organ-on-a-chip advances towards clinically relevant pharmaceutical and medical in vitro models.","volume":"55","author":"Rothbauer","year":"2019","journal-title":"Curr. Opin. Biotechnol."},{"key":"B157","first-page":"810","article-title":"Cell therapy for heart failure.","volume":"113","author":"Sanganalmath","year":"2013","journal-title":"Curr. Cardiol. Rev."},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3719","article-title":"Titin-truncating variants affect heart function in disease cohorts and the general population.","volume":"49","author":"Schafer","year":"2016","journal-title":"Nat. Genet."},{"key":"B159","doi-asserted-by":"crossref","DOI":"10.1038\/s41572-019-0084-1","article-title":"Dilated cardiomyopathy.","volume":"5","author":"Schultheiss","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"key":"B160","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1096\/fj.08-127373","article-title":"Targeting VEGF-encapsulated immunoliposomes to MI heart improves vascularity and cardiac function.","volume":"23","author":"Scott","year":"2009","journal-title":"FASEB J."},{"key":"B161","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nature11682","article-title":"Mammalian heart renewal by pre-existing cardiomyocytes.","volume":"493","author":"Senyo","year":"2013","journal-title":"Nature"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2015.00286","article-title":"Advances and challenges of liposome assisted drug delivery.","volume":"6","author":"Sercombe","year":"2015","journal-title":"Front. Pharmacol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1161\/hc0802.104407","article-title":"Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2.","author":"Simons","year":"2002"},{"key":"B164","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1517\/17425247.2.4.639","article-title":"On the delivery of small interfering RNAs into mammalian cells.","volume":"2","author":"Sioud","year":"2005","journal-title":"Expert Opin. Drug Deliv."},{"key":"B165","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1161\/atvbaha.109.197434","article-title":"MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells.","volume":"30","author":"Sluijter","year":"2010","journal-title":"Arteriosclerosis Thrombosis Vasc. Biol."},{"key":"B166","doi-asserted-by":"publisher","first-page":"4218","DOI":"10.1073\/pnas.1000300107","article-title":"Regulation of PI3-kinase\/Akt signaling by muscle-enriched microRNA-486.","volume":"107","author":"Small","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B167","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1038\/nprot.2014.113","article-title":"Isolation and characterization of resident endogenous c-Kit+ cardiac stem cells from the adult mouse and rat heart.","volume":"9","author":"Smith","year":"2014","journal-title":"Nat. Protoc."},{"key":"B168","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nature11139","article-title":"Heart repair by reprogramming non-myocytes with cardiac transcription factors.","volume":"485","author":"Song","year":"2012","journal-title":"Nature"},{"key":"B169","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrcardio.2013.94","article-title":"Vascular endothelial growth factor in heart failure.","volume":"10","author":"Taimeh","year":"2013","journal-title":"Nat. Rev. Cardiol."},{"key":"B170","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/cphy.c140055","article-title":"Pathophysiology of heart failure.","volume":"6","author":"Tanai","year":"2015","journal-title":"Compr. Physiol."},{"key":"B171","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-13591-7","article-title":"LATS1 but not LATS2 represses autophagy by a kinase-independent scaffold function.","volume":"10","author":"Tang","year":"2019","journal-title":"Nat. Commun."},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1038\/nature17959","article-title":"Pitx2 promotes heart repair by activating the antioxidant response after cardiac injury.","volume":"534","author":"Tao","year":"2016","journal-title":"Nature"},{"key":"B173","year":"2019"},{"key":"B174","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1038\/nature07511","article-title":"MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts.","volume":"456","author":"Thum","year":"2008","journal-title":"Nature"},{"key":"B175","doi-asserted-by":"crossref","first-page":"ra38","DOI":"10.1126\/scitranslmed.3010841","article-title":"A microRNA-Hippo pathway that promotes cardiomyocyte proliferation and cardiac regeneration in mice.","volume":"7","author":"Tian","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"B176","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1016\/j.celrep.2019.05.005","article-title":"Common regulatory pathways mediate activity of microRNAs inducing cardiomyocyte proliferation.","volume":"27","author":"Torrini","year":"2019","journal-title":"Cell Rep."},{"key":"B177","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jacbts.2019.07.012","article-title":"First-in-man study of a cardiac extracellular matrix hydrogel in early and late myocardial infarction patients.","volume":"4","author":"Traverse","year":"2019","journal-title":"JACC"},{"key":"B178","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.tem.2013.12.002","article-title":"New insights into IGF-1 signaling in the heart.","volume":"25","author":"Troncoso","year":"2014","journal-title":"Trends Endocrinol. Metabol."},{"key":"B179","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1126\/science.aam5894","article-title":"Cardiac regeneration strategies: staying young at heart.","volume":"356","author":"Tzahor","year":"2017","journal-title":"Science"},{"key":"B180","year":"2013","journal-title":"Health Topic: Cardiomyopathy"},{"key":"B181","year":"","journal-title":"Nanoparticles in Heart Diseases: Overview on the Existing Clinical Trials"},{"key":"B182","year":"","journal-title":"VEGF in Heart Diseases: Overview on the Existing Clinical Trials"},{"key":"B183","year":"2013","journal-title":"IRon Nanoparticle Enhanced MRI in the Assessment of Myocardial infarctioN (IRNMAN)"},{"key":"B184","year":"","journal-title":"Ferumoxytol for Magnetic Resonance Imaging of Myocardial Infarction."},{"key":"B185","year":"","journal-title":"Inflammatory Cell Trafficking After Myocardial Infarction"},{"key":"B186","article-title":"A Study of VentriGel in Post-MI Patient","year":""},{"key":"B187","year":"","journal-title":"The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial (TAC-HFT-II)"},{"key":"B188","year":"","journal-title":"Bone Marrow Derived Mesenchymal Stem Cells in Improving Heart Function in Patients With Heart Failure Caused by Anthracyclines"},{"key":"B189","year":"","journal-title":"CardiAMP<sup>TM<\/sup> Heart Failure Trial"},{"key":"B190","year":"","journal-title":"Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure (DREAM HF-1)"},{"key":"B225","year":""},{"key":"B226","year":""},{"key":"B191","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1016\/s0002-9149(00)00787-6","article-title":"Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris.","volume":"85","author":"Unger","year":"2000","journal-title":"Am. J. Cardiol."},{"key":"B192","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells.","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"B193","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17425247.2017.1262346","article-title":"Cancer nanomedicines: oversold or underappreciated?","volume":"14","author":"van der Meel","year":"2017","journal-title":"Expert Opin. Drug Deliv."},{"key":"B194","doi-asserted-by":"publisher","first-page":"18255","DOI":"10.1073\/pnas.0608791103","article-title":"A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure.","volume":"103","author":"van Rooij","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B195","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1242\/dev.102376","article-title":"The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease.","volume":"141","author":"Varelas","year":"2014","journal-title":"Development"},{"key":"B196","article-title":"Outcomes of contemporary family screening in hypertrophic cardiomyopathy.","volume":"11","author":"Velzen","year":"2018","journal-title":"Circulation"},{"key":"B197","doi-asserted-by":"publisher","first-page":"2101","DOI":"10.1038\/cdd.2017.130","article-title":"Adult cardiac stem cells are multipotent and robustly myogenic: c-kit expression is necessary but not sufficient for their identification.","volume":"24","author":"Vicinanza","year":"2017","journal-title":"Cell Death Differ."},{"key":"B198","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082234","article-title":"Cardiomyopathies and related changes in contractility of human heart muscle.","volume":"19","author":"Vikhorev","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"B199","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1073\/pnas.1116136109","article-title":"YAP1, the nuclear target of Hippo signaling, stimulates heart growth through cardiomyocyte proliferation but not hypertrophy.","volume":"109","author":"von Gise","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B200","doi-asserted-by":"crossref","first-page":"12667","DOI":"10.1073\/pnas.1304053110","article-title":"Induction of human cardiomyocyte-like cells from fibroblasts by defined factors.","volume":"110","author":"Wada","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B201","doi-asserted-by":"publisher","DOI":"10.1038\/nature13073","article-title":"Inhibition of miR-25 improves cardiac contractility in the failing heart.","volume":"508","author":"Wahlquist","year":"2014","journal-title":"Nature"},{"key":"B202","doi-asserted-by":"publisher","first-page":"11495","DOI":"10.3390\/ijms150711495","article-title":"Exposure to AT1 receptor autoantibodies during pregnancy increases susceptibility of the maternal heart to postpartum ischemia-reperfusion injury in rats.","volume":"15","author":"Wang","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"B203","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/s41569-018-0063-3","article-title":"The Hippo pathway in the heart: pivotal roles in development, disease, and regeneration.","volume":"15","author":"Wang","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"B204","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1126\/science.1216210","article-title":"Photoacoustic tomography: in vivo imaging from organelles to organs.","volume":"335","author":"Wang","year":"2012","journal-title":"Science"},{"key":"B205","first-page":"1643","article-title":"Inherited cardiomyopathies.","volume":"364","author":"Watkins","year":"2011","journal-title":"Circ. J."},{"key":"B206","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms7048","article-title":"The Hippo pathway effector YAP is a critical regulator of skeletal muscle fibre size.","volume":"6","author":"Watt","year":"2015","journal-title":"Nat. Commun."},{"key":"B207","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1097\/moh.0b013e3282f97d86","article-title":"Vascular permeability in cardiovascular disease and cancer.","volume":"15","author":"Weis","year":"2008","journal-title":"Curr. Opin. Hematol."},{"key":"B208","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/s41551-018-0247-5","article-title":"Sustained release of targeted cardiac therapy with a replenishable implanted epicardial reservoir.","volume":"2","author":"Whyte","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"B209","year":"2019","journal-title":"Cardiovascular Diseases (CVDs)."},{"key":"B210","doi-asserted-by":"crossref","first-page":"12515","DOI":"10.1039\/c2ra21263c","article-title":"Gold nanoparticles as computerized tomography (CT) contrast agents.","volume":"2","author":"Xi","year":"2012","journal-title":"RSC Adv."},{"key":"B211","doi-asserted-by":"crossref","DOI":"10.1038\/srep08579","article-title":"Cardioprotective activity of iron oxide nanoparticles.","volume":"5","author":"Xiong","year":"2015","journal-title":"Sci. Rep."},{"key":"B212","article-title":"Genotype-phenotype relationship in patients with arrhythmogenic right ventricular cardiomyopathy caused by desmosomal gene mutations: a systematic review and meta-analysis.","volume":"7","author":"Xu","year":"2017","journal-title":"Sci. Rep."},{"key":"B213","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.nano.2017.12.004","article-title":"Delivery of microRNA-1 inhibitor by dendrimer-based nanovector: an early targeting therapy for myocardial infarction in mice.","volume":"14","author":"Xue","year":"2018","journal-title":"Nanomedicine"},{"key":"B214","doi-asserted-by":"publisher","first-page":"9880","DOI":"10.1021\/acsnano.9b03343","article-title":"An in vivo miRNA delivery system for restoring infarcted myocardium.","volume":"13","author":"Yang","year":"2019","journal-title":"ACS Nano"},{"key":"B215","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.nantod.2011.10.001","article-title":"Toxicology and clinical potential of nanoparticles.","volume":"6","author":"Yildirimer","year":"2011","journal-title":"Nano Today"},{"key":"B216","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/sctm.18-0244","article-title":"Cardiac regeneration by statin-polymer nanoparticle-loaded adipose-derived stem cell therapy in myocardial infarction.","volume":"8","author":"Yokoyama","year":"2019","journal-title":"Stem Cells Transl. Med."},{"key":"B217","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jconrel.2015.10.012","article-title":"Nanotechnology for protein delivery: overview and perspectives.","volume":"240","author":"Yu","year":"2016","journal-title":"J. Control. Release"},{"key":"B218","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/s0002-9149(03)00533-2","article-title":"Efficacy and safety of berberine for congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.","volume":"92","author":"Zeng","year":"2003","journal-title":"Am. J. Cardiol."},{"key":"B219","doi-asserted-by":"publisher","first-page":"18544","DOI":"10.1002\/jcp.28492","article-title":"Silica-coated magnetic nanoparticles labeled endothelial progenitor cells alleviate ischemic myocardial injury and improve long-term cardiac function with magnetic field guidance in rats with myocardial infarction.","volume":"234","author":"Zhang","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"B220","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/sj.clpt.6100400","article-title":"Nanoparticles in medicine: therapeutic applications and developments.","volume":"83","author":"Zhang","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"B221","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2007.07.016","article-title":"Cationic lipids and polymers mediated vectors for delivery of siRNA.","volume":"123","author":"Zhang","year":"2007","journal-title":"J. Controll. Release"},{"key":"B222","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1039\/c6tb00308g","article-title":"Polymer-based nanoparticles for protein delivery: design, strategies and applications.","volume":"4","author":"Zhao","year":"2016","journal-title":"J. Mater. Chem. B"},{"key":"B223","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.cell.2007.03.030","article-title":"Dysregulation of cardiogenesis, cardiac conduction, and cell cycle in mice lacking miRNA-1-2.","volume":"129","author":"Zhao","year":"2007","journal-title":"Cell"},{"key":"B224","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/nature03817","article-title":"Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis.","volume":"436","author":"Zhao","year":"2005","journal-title":"Nature"}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fbioe.2020.00323\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,24]],"date-time":"2020-04-24T04:48:10Z","timestamp":1587703690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fbioe.2020.00323\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,24]]},"references-count":226,"alternative-id":["10.3389\/fbioe.2020.00323"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2020.00323","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,24]]},"article-number":"323"}}